- Home
- ELDN vs RLTY Comparison
ELDN vs RLTY Comparison
Compare ELDN & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- RLTY
- Stock Information
- Founded
- ELDN 2004
- RLTY 2022
- Country
- ELDN United States
- RLTY United States
- Employees
- ELDN N/A
- RLTY N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- ELDN Health Care
- RLTY Finance
- Exchange
- ELDN Nasdaq
- RLTY Nasdaq
- Market Cap
- ELDN 178.4M
- RLTY 259.2M
- IPO Year
- ELDN N/A
- RLTY N/A
- Fundamental
- Price
- ELDN $3.17
- RLTY $15.10
- Analyst Decision
- ELDN Strong Buy
- RLTY
- Analyst Count
- ELDN 1
- RLTY 0
- Target Price
- ELDN $16.00
- RLTY N/A
- AVG Volume (30 Days)
- ELDN 150.4K
- RLTY 86.7K
- Earning Date
- ELDN 05-20-2025
- RLTY 01-01-0001
- Dividend Yield
- ELDN N/A
- RLTY 9.35%
- EPS Growth
- ELDN N/A
- RLTY N/A
- EPS
- ELDN N/A
- RLTY N/A
- Revenue
- ELDN N/A
- RLTY N/A
- Revenue This Year
- ELDN N/A
- RLTY N/A
- Revenue Next Year
- ELDN N/A
- RLTY N/A
- P/E Ratio
- ELDN N/A
- RLTY N/A
- Revenue Growth
- ELDN N/A
- RLTY N/A
- 52 Week Low
- ELDN $2.00
- RLTY $11.38
- 52 Week High
- ELDN $5.54
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- ELDN 48.82
- RLTY 56.69
- Support Level
- ELDN $2.85
- RLTY $15.06
- Resistance Level
- ELDN $3.51
- RLTY $15.40
- Average True Range (ATR)
- ELDN 0.25
- RLTY 0.29
- MACD
- ELDN 0.01
- RLTY 0.10
- Stochastic Oscillator
- ELDN 45.07
- RLTY 77.24
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.